Activation of NFAT by TRPC6 mutants was blocked by inhibitors of calcineurin, calmodulin-dependent kinase II, and phosphatidylinositol 3-kinase thus identifying the activation of the calcineurin-NFAT pathway as a potential mediator of FSGS. Here, TRPC6 is linked to focal segmental glomerulosclerosis.